Mon, 30th Jul 2018 16:11
LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.
Through a combination of contracts for difference and ordinary shares, Spreadex's holding was 3.9 million shares. Its previous holding in Venn, if any, has not been disclosed.
Shares in Venn Life Sciences were down 1.2% at 6.18 pence on Monday.
(Alliance News) - Shares in Open Orphan PLC began trading in London on Friday following the combination of Venn Life Sciences Holdings PLC and Open Or...
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.5...
LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Tuesday said it has conditionally raised GBP4.5 million before expenses through a share pl...
LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it is acquiring Open Orphan DAC in an all-share acquisition and planning an eq...
LONDON (Alliance News) - Venn Life Sciences Holdings PLC on Monday said Raglan Capital Ltd, of whom Cathal Friel is a principal and owner, has subscri...
